Galenica AG engages in the provision of health care. The company is headquartered in Bern, Bern and currently employs 6,125 full-time employees. The company went IPO on 2017-04-07. The firm's business i divided into three business sectors: Retail, Products & Brands, and Services. The firm manages a locally established pharmacies network in Switzerland. The company develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.
How did GALNF's recent EPS compare to expectations?
The most recent EPS for Galenica AG is $, expectations of $.
How did Galenica AG GALNF's revenue perform in the last quarter?
Galenica AG revenue for the last quarter is $
What is the revenue estimate for Galenica AG?
According to of Wall street analyst, the revenue estimate of Galenica AG range from $ to $
What's the earning quality score for Galenica AG?
Galenica AG has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Galenica AG report earnings?
Galenica AG next earnings report is expected in 2026-06-08
What are Galenica AG's expected earnings?
Galenica AG expected earnings is $, according to wall-street analysts.